Total Funding
87
61
Total FundingPost-IPO Equity raised
Growth Score
-9 pts
Heat Score
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
12319
Mirxes is an RNA technology company that develops blood-based miRNA test kits for early disease detection.
- Zou Ruiyang: Co-Founder, Director, and Chief Technology Officer
- Veronica Chew: Head of Open Innovation and Emerging TechnologiesPast Role: Healint, CMO & Co-founder
About the Company
Mirxes is a biotechnology company that discovers, develops, and delivers accurate preventive healthcare solutions for cancer, cardiovascular, metabolic and infectious diseases. The company's mission is to make diagnostic solutions for the early detection of diseases accessible on a global scale. It develops and commercializes accurate and
non-invasive blood-based miRNA test kit products for the early detection of cancer and other diseases.
